openPR Logo
Press release

Biosimilars Market Analysis to 2025 with Biocon, Samsung BioLogics, Mylan, Amgen, Celltrion, Healthcare, Sandoz International, Teva Pharmaceutical Industries, Pfizer, STADA Arzneimittel, Dr. Reddy’s Laboratories

02-11-2019 01:19 PM CET | Health & Medicine

Press release from: The Insight Partners

Biosimilars Market to 2025

Biosimilars Market to 2025

The report provides a detailed overview on the industry including both qualitative and quantitative information. It provides overview and forecast of the global biosimilars based on product and application. It also provides market size and forecast till 2025 for overall biosimilars market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East &Africa (MEA) and South & Central America. The market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 countries globally along with current trend and opportunities prevailing in the region.

The key players influencing the market are Teva Pharmaceutical Industries Ltd., Pfizer Inc., Biocon, Samsung BioLogics, Mylan N.V., Amgen Inc., Celltrion, Healthcare Co.,Ltd., Sandoz International GmbH, STADA Arzneimittel AG, Dr. Reddy’s Laboratories Ltd. and others.

The growth of the global biosimilars market can be attributed to the growing demand of pharmaceutical drug supplements, especially for the high priced patented drugs expected to upsurge the growth of the market. Additionally, increasing incidences of chronic diseases add novel opportunities for the global biosimilars market over the forecast period.

Get sample copy: http://bit.ly/2TJLfBZ

On the basis of product the market is segmented into recombinant non-glycosylated proteins, recombinant glycosylated proteins, peptides and others. The recombinant non-glycosylated proteins market is further segmented into insulin, recombinant human growth hormone, granulocyte colony-stimulating factor and interferons. The recombinant glycosylated proteins segment is bifurcated into monoclonal antibodies and erythropoietin. The peptides segment is also classified into calcitonin and glucagon. Based on application the market is segmented into oncology, autoimmune diseases, chronic diseases, blood disorders, infectious diseases, growth hormone deficiency and others.

A biosimilar is a biological product which is similar to an FDA approved biologic product of another manufacturer. Owing to the complexities associated with development & manufacture of biosimilar products, these are manufactured by companies with highly skillful workforce and deep scientific expertise. The FDA approval process for biosimilar products is rigorous and enables high safety to the end users.

The report analyzes factors affecting market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the market in these regions.

Buy this report: http://bit.ly/2TIt4wP

TABLE OF CONTENTS

1 Introduction
1.1 Scope of Study
1.2 The Insight Partners Research Report Guidance

2 Key Takeaways

3 Biosimilars Market Landscape
3.1 Market Overview
3.2 Market Segmentation
3.2.1 Biosimilars Market – By Product
3.2.2 Biosimilars Market – By Application
3.2.3 Biosimilars Market – By Region
3.2.3.1 By Country
3.3 PEST Analysis
3.3.1 North America – PEST Analysis
3.3.2 Europe – PEST Analysis
3.3.3 Asia Pacific – PEST Analysis
3.3.4 Middle East and Africa – PEST Analysis
3.3.5 South and Central America – PEST Analysis

4 Biosimilars Market – Key Industry Dynamics
4.1 Key Market Drivers
4.2 Key Market Restraints
4.3 Key Market Opportunities
4.4 Future Trends
4.5 Impact Analysis

5 Biosimilars Market - Global Analysis
5.1 Global Biosimilars Market Overview
5.2 Global Biosimilars Market Revenue Forecasts and Analysis (US$ Mn)
5.3 Market Positioning/Market Share
5.4 Performance of Key Players
5.5 Clinical Trial Analysis
5.6 Expert Opinions

About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense.

Contact Us:
Call: +1-646-491-9876
Email: sales@theinsightpartners.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Biosimilars Market Analysis to 2025 with Biocon, Samsung BioLogics, Mylan, Amgen, Celltrion, Healthcare, Sandoz International, Teva Pharmaceutical Industries, Pfizer, STADA Arzneimittel, Dr. Reddy’s Laboratories here

News-ID: 1576951 • Views: 575

More Releases from The Insight Partners

Gamification in Education Market Expanding Massively by 2020-2027 Profiling Lead …
The gamification in learning is an educational approach which helps learners to motivate to learn using video game design and elements in learning environments. The purpose is enjoyment and engagement by capturing the interest of learners and inspiring them to continue learning. Gamification in education helps learners to master the skill or information, as they put them to competition or challenges. The gamification in education market is heavily influenced by driving
Projection Mapping Market Analysis by Top Industry Experts - Urban Projection, W …
"Projection Mapping Industry" report presents the Competitive Scenario of the Major Players based on the Sales Revenue, Demands, Company Profile, Future Scope, Upcoming Growth Opportunities which will help the Emerging Market in making business conclusion of Projection Mapping Market. The Projection Mapping is a result of evolution in the projection technology, where the image is precisely mapped onto the contours and features of any object. When coupled with careful pre-production, the
Nutraceutical Ingredients Market Outlook: Business Opportunities, Survey, Growth …
Latest Report Titled on "Nutraceutical Ingredients Market to 2027 - Global Analysis and Forecasts by Health Benefits (Cognitive Health, Gut Health, Heart Health, Bone Health, Immunity, Nutrition, Weight Management, Others); Type (Probiotic, Proteins and Amino Acids, Phytochemical and Plant Extracts, Fibers and Specialty Carbohydrates, Omega-3 Fatty Acids, Vitamins, Prebiotic, Carotenoids, Minerals, Others); Application (Food, Beverages, Personal Care, Animal Nutrition, Dietary Supplement); Form (Dry, Liquid) and Geography" Get Sample Copy of this
Research Report Analysis on Parking Reservation System Market 2019 Qualitative a …
The report analyzes factors affecting parking reservation system market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period, i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South & Central America after evaluating political, economic, social and technological factors affecting the parking reservation system market

All 5 Releases


More Releases for Biosimilars

PHASE-XS – Access To Life Changing Biosimilars
Biopharmaceutical is one of the fastest growing industries with addition of numerous biologics that provide novel treatment modalities for life-threatening and rare diseases. Biologics are produced from living organisms through unique manufacturing and purification processes. It includes a wide variety of products such as vaccines, blood, blood components, cells, allergens, genes, tissues, and recombinant proteins that are derived from human, animal or microorganisms by using biotechnological procedures. Some examples for
Global Biosimilars Market Research Report
This report studies the global Biosimilars market status and forecast, categorizes the global Biosimilars market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia). The major manufacturers covered in this report Pfizer Sandoz International GmbH Teva Pharmaceuticals Industries Amgen Inc Biocon Dr. Reddy’s Laboratories F. Hoffmann-La Roche Celltrion Samsung Bioepis
Insulin Biosimilars Market, by Biosimilar Type Rapid-acting Biosimilars, Long-ac …
Diabetes is a group of metabolic disease characterized by high blood sugar level due to inadequate secretion of insulin. Common symptoms of diabetes include increased hunger, tiredness, weight loss, and excessive thirst and urination. The prevalence of diabetes is increasing, in turn, boosting demand for insulin biosimilar. For instance, according the World Health Organization (WHO) report in 2014, globally around 422 million adults were living with diabetes and 1.5 million
Insulin Biosimilars Market, by Biosimilar Type Rapid-acting Biosimilars, Long-ac …
Biosimilar is a medicine developed on the original biological reference product. The production process of biopharmaceuticals vary from one manufacturer to another, thus every biosimilar product is unique from the other. Biosimilar manufactures use different culture conditions, master cell lines, purification techniques, and raw materials. This in turn, helps meet the rising prevalence of diabetes due to inadequate healthcare services, rising prevalence of obesity, For instance, According to 2013 American
Humira Biosimilars Clinical Trial Insight
“Humira Biosimilars Clinical Trial Insight” report by PNS Pharma gives comprehensive clinical insight on 33 biosimilars version of Humira drug in clinical pipeline. More than 10 of these biosimilars are in Phase-III trials and are expected to be commercially available in next 5-8 years. The patent protection assigned to Humira will expire in 2016 for US and 2018 for European market.
Enbrel Biosimilars Clinical Trial Insight
“Enbrel Biosimilars Clinical Trial Insight” report by PNS Pharma gives comprehensive clinical insight on 36 biosimilars version of Enbrel drug in clinical pipeline. More than 5 of these biosimilars are in Phase-III trials and are expected to be commercially available in next 5-8 years. Currently 5 biosimilar version of Enbrel are commercially available in Iran, Mexico, India, UK and Australia. The patent on Enbrel was originally set to expire on